Navigation Links
Big Pharma Chemists Turning Out in Large Numbers for ChemOutsourcing Extravaganza Event on September 14-16, 2010 at Jersey Shore Beach Resort
Date:7/27/2010

LONG BRANCH, N.J., July 27 /PRNewswire/ -- For the first time ever, large numbers of personnel from the world's largest pharmaceutical companies have been registering to attend Pharma ChemOutsourcing at the Jersey Shore this fall. Most are chemists by training and work in the exploding field of outsourcing/sourcing active pharmaceutical ingredients (API's).

Pharma ChemOutsourcing has found a home on the East Coast where the majority of the large pharmaceutical companies and their suppliers are located. "We have good working relationships with Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly, Roche, GSK, and Novartis, for example, and they often provide guidance to make the show more relevant to their current needs," Alexay continued. "We get a lot of input".

"The event is growing at a 35% rate this year," says Mark Alexay the event organizer, "but what distinguishes this year's attendance is that the large pharma companies are coming in much greater numbers than years past. This is evident in the sharply higher turnout from the respective companies. The Big Pharma attendees say that it's a convenient place to accomplish several high priority goals in a short period of time – there's a LOT of information in the conference sessions plus they meet their suppliers."

The event features 4 parallel tracks over 3 days, 150 speakers, 100 exhibitors, 1000 attendees, and is studded with nightly socializing events on the beach for effective networking. "People set up meetings before the show but the evening parties over several nights help people make new connections. It's much easier to approach someone new in a social setting away from the conference hotel," remarked Alexay.

The 2010 attendee list may be viewed at http://chemoutsourcing.com/attendees.php

The 100 exhibitors are at http://chemoutsourcing.com/sponsors.php

The 2009 Beach Party can be viewed at http://www.youtube.com/watch?v=zTGzZhqDjcU&feature=fvw

For additional information about the extravaganza chemistry event visit www.chemoutsourcing.com or contact Mark Alexay at +1-201-452-4023, or malexay@chemoutsourcing.com


'/>"/>
SOURCE Apaporis LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... Sharon Kleyne is proud of the ... research center at Bio-Logic Aqua Research® Water Life Science®, has been released in ... sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to eliminating ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing ... by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the ... 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower ...
Breaking Medicine News(10 mins):